Skip to main content

Amiodarone News

Acupuncture Aids Outcomes After Heart Valve Surgery

FRIDAY, Oct. 27, 2023 – Acupuncture after heart valve surgery is feasible and safe and has clinical benefit, according to a study recently published in JTCVS Open.  Kim L. Feingold, Ph.D., from N...

Bleeding-Linked Hospitalization Up With Amiodarone in A-Fib

TUESDAY, May 23, 2023 – For patients with atrial fibrillation receiving apixaban or rivaroxaban, the risk of bleeding-related hospitalizations is greater during amiodarone treatment than flecainide...

FDA Medwatch Alert: Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone

[Posted 03/24/2015] ISSUE: FDA is warning that serious slowing of the heart rate can occur when the antiarrhythmic drug amiodarone is taken together with either the hepatitis C drug Harvoni...

FDA Medwatch Alert: Needleless Pre-filled Glass Syringes: Stakeholder Advisory - Compatibility Problems with Needleless Intravenous Access Systems

Reports Received on Adenosine and Amiodarone Products   [UPDATED 05/06/2011] FDA recommends that, to reduce the potential risks to patients, healthcare professionals and risk managers stock crash ...

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection

KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ – Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the supplemental new drug application for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Arrhythmia, Supraventricular Tachycardia

Amiodarone patient information at Drugs.com